Anemia and growth retardation associated with Schistosoma haematobium infection in Mali: a possible subtle impact of a neglected tropical disease

Trans R Soc Trop Med Hyg. 2017 Apr 1;111(4):144-153. doi: 10.1093/trstmh/trx037.

Abstract

Background: The aim of this cross-sectional study was to investigate a possible association of Schistosoma haematobium with child growth development and describe a plausible schistosomiasis-related anemia in children and adults in a highly schistosomiasis endemic area of Mali.

Methods: Urine, feces and blood samples from 399 participants of both sexes (2-40 years of age) were analyzed and supplemented by anthropometric measurements.

Results: S. haematobium prevalence was 79.8%, S. mansoni 13.2% and Plasmodium falciparum 80.2%. S. haematobium infection intensity as five categories was significantly associated with anemia; i.e., odds of having anemia in the highest and the next highest category was 3.25 (95% CL 1.61-6.55; p<0.01) and 2.45 (95% CL 1.28-4.70; p<0.01), respectively, of that in the three lower categories combined after adjusting for age group and gender and the interaction between the two factors. Anemia was most pronounced in the 2-5 year olds males (55.5%, n=98). P. falciparum infection was not significantly associated with anemia. Stunting (body mass index [BMI] for age z-score<-2.00) was observed in 2.6% (2/78) of the 2-5 years olds and in 7.7% (14/182) in the 6-19 years age group. Lower BMI-z-scores (as continuous variable) were associated with anemia (p<0.05) while high intensity of S. haematobium infection was not significant when adjusting for age group and anemia. Participants with malaria infection had lower z-scores (as continuous variables) of weight and height for age. Lower height for age z-scores were also associated with anemia.

Conclusions: S. haematobium infection is likely to impact on child growth and possibly also anemia in all age groups and advocates for inclusion of whole populations into future control programes.

Keywords: Anemia; Growth; Morbidity; NTD; Schistosomiasis; Sub-Saharan Africa.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Albendazole / therapeutic use
  • Anemia / epidemiology
  • Anemia / parasitology*
  • Anemia / physiopathology
  • Animals
  • Anthelmintics / therapeutic use
  • Body Mass Index
  • Child
  • Child, Preschool
  • Cognitive Dysfunction / epidemiology
  • Cognitive Dysfunction / parasitology*
  • Cognitive Dysfunction / physiopathology
  • Cross-Sectional Studies
  • Endemic Diseases
  • Feces / parasitology*
  • Female
  • Growth Disorders / epidemiology
  • Growth Disorders / parasitology*
  • Growth Disorders / physiopathology
  • Humans
  • Male
  • Mali / epidemiology
  • Praziquantel / therapeutic use
  • Prevalence
  • Schistosoma haematobium / isolation & purification*
  • Schistosomiasis haematobia / complications*
  • Schistosomiasis haematobia / drug therapy
  • Schistosomiasis haematobia / epidemiology
  • Schistosomiasis haematobia / physiopathology
  • Young Adult

Substances

  • Anthelmintics
  • Praziquantel
  • Albendazole